ERBB2 and cancer: While it appears that an up-regulation of ErbB2 in hearts in cancer patients might initially offer protection from toxic effects of doxorubicin, long-term effects of ErbB2 over-expression, particularly when not induced as a response to doxorubicin treatment, are unknown.